Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

This book is a direct result of 10 years of the well-known ""Autoimmunity Days"" in Israel, which are increasingly becoming an international focal point for autoimmunity scientists. Top researchers provide coverage of the most important knowledge generated during the last decade. The volume can therefore be seen almost as a textbook on autoimmunity, projecting from the last decade to the next millennium. A variety of different subjects in autoimmunity, from etiology to pathogenesis, from postulated mechanisms to innovative therapeutic modalities, is handled by noted contributors, while a

Autoimmune diseases --- Autoimmunity --- Autoimmune Diseases. --- Autoimmunity.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The break on immune tolerance is a common point between autoimmune diseases and the uncontrolled effector immune responses against allo-antigens in transplantation. Among the past years, several approaches to restore a suppressive immune state have included the targeting of co-stimulatory/inhibitory molecules on immune cells, the promotion or blockade of pivotal cytokines, and the extensive study on how to isolate and expand suppressive cells with the purpose to re-infuse them in patients. To date, the availability of new technologies has permitted to learn, in a more detailed way, the immune mechanisms carried out by suppressive lymphocytes, together with the identification of new potential candidates to target in our quest for immune tolerance. For example, the attractive concepts of lymphocyte plasticity and function stability, supported by the finding of new transcription factors, have opened a new window in the understanding of T cell differentiation, effector cell commitment and immune regulatory function. On the other hand, the discovery of new members of the Ig superfamily ligand, VISTA; the intriguing role of modulatory molecules like Retinoic Acid, Neuropilin-1, Fc gamma receptors, or cytokines such as IL-33, among others, are revealing new possibilities in the development of new strategies to conquer our obsession: immune tolerance. Here, we gather the latest information regarding new targets and cellular processes, including an update on current cellular therapies and the exciting coming approaches to cure autoimmunity and permit transplant acceptance.

Autoimmunity --- immuneregulation --- Transplantation --- tolerance

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Autoantibodies. --- Autoantibodies --- Autoimmunity. --- Autoallergy --- Immunity --- Immunodiagnosis --- Immunoglobulins --- Autoimmunity --- Analysis.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Infection and Autoimmunity

Autoimmune diseases --- Infection. --- Autoimmunity. --- Etiology.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Interferons (IFN) belong to the family of cytokines and have been described first in the late 1950s as an inhibitory factor of viral replication. Since then, the impact of interferon has been greatly expanded and its function comprises a role not only in different types of infection, cancer and autoimmunity but importantly also in immunehomeostasis. IFN have important anti-viral effects but it is becoming more and more evident that they are true immunomodulators and have an important impact on the development and maintenance of innate and adaptive immunity.

interferons --- IFN --- immunehomeostasis --- autoimmunity --- mmunomodulators